Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities

  Рет қаралды 7,696

Stanford APDA

Stanford APDA

Күн бұрын

Пікірлер: 8
@robertbernard651
@robertbernard651 Жыл бұрын
What can we do to help this process?
@zhuzhou
@zhuzhou Жыл бұрын
BTW Ambroxol, while OTC in Europe, is not FDA approved in the united states.
@ottoavila9895
@ottoavila9895 2 жыл бұрын
Can ll-37 inhibit alpha-synuclein?
@douglaswatt1582
@douglaswatt1582 9 ай бұрын
It's still amazes me when senior people who should know better talk about aggregated proteins in neurodegenerative disorders as simple causes instead of markers or as causes in interaction. Contrary to the overconfident protein-centric view of neurodegenerative disorders, we actually don't understand what's causing them. And to describe aggregated protein is the cause obscures the simple fact that we don't know where these protein aggregates really come from or how they get started or how they escaped protein quality control, in other words the failure of proteostasis has to be antecedent to these aggregates spreading. In addition, the aggregates aren't simply a cause of inflammation they are often times spread via inflammation and changes in the glial system, famously the Tauopathy in Alzheimer's disease. Additionally there are over two dozen monoclonal antibody therapies that have failed to show disease modification or that show only very minimal slowing of degeneration despite the success that these oftentimes have in removing the protein villain. So this whole proteinopathic theory of neurodegeneration has serious challenges and even more serious holes in it. This is not to suggest the ridiculous notion that protein aggregates are not contributing to neurodegeneration, because that's also ridiculous. But it is not by any conceivable stretch a complete theory of neurodegeneration and far from a guide to treating clinical stage disease.
@supremoluminary
@supremoluminary 7 ай бұрын
“She received her medical training in Germany and umm uhh later on umm a umm study genetics..” If you can’t speak, don’t. People come to the Internet to get information. We are not captive audience submissively held captive to kiss up to the professor in order to get a grade. As a teacher, as a speaker, you fail.
@Ofsside.Edits.football
@Ofsside.Edits.football 26 күн бұрын
The talk is very good. Its a pity that you are unable to focus on the content.
Alpha-Synuclein - What's it all about?
22:15
Oxford Parkinson's Disease Centre
Рет қаралды 25 М.
Alpha-Synuclein Strains in Synucleinopathies
31:46
Labroots
Рет қаралды 985
The Ultimate Sausage Prank! Watch Their Reactions 😂🌭 #Unexpected
00:17
La La Life Shorts
Рет қаралды 7 МЛН
Из какого города смотришь? 😃
00:34
МЯТНАЯ ФАНТА
Рет қаралды 2,2 МЛН
Getting the Best Treatment for YOUR PD
1:11:06
Stanford APDA
Рет қаралды 177
Robert Sapolsky: The Biology of Humans at Our Best and Worst
1:13:13
Stanford Iranian Studies Program
Рет қаралды 983 М.
APOE TREM and Microglia in the Pathogenesis of Tau-mediated Neurodegeneration with David Holtzman MD
52:06
University of California Television (UCTV)
Рет қаралды 18 М.
AMA #15: Fluoride Benefits/Risks & Vagus Nerve Stimulation
29:03
Andrew Huberman
Рет қаралды 109 М.
Aging Is Not Inevitable: Are Stem Cells the Fountain of Youth?
32:19
Stanford Medicine
Рет қаралды 144 М.
Caring for the Whole Person (Neuro-Palliative Care)
59:33
Stanford APDA
Рет қаралды 52
The Ultimate Sausage Prank! Watch Their Reactions 😂🌭 #Unexpected
00:17
La La Life Shorts
Рет қаралды 7 МЛН